APO Research

APO RESEARCH · REPORT

Biobanking

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Product & engineering

Understand the product.

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Selected research

Industry Growth & Trends

Global Biobanking Industry Growth and Trends Forecast to 2032

Market perspective

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

According to APO Research, the global Biobanking market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Biobanking market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biobanking market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biobanking market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biobanking.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biobanking market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biobanking Market by Company

Thermo Fisher

Beckman Coulter

Panasonic

SOL Group

Promega

Merck

Greiner Bio One

Chart Industries

Brooks Life Science

Tecan Group

QIAGEN

BD

Lifeline Scientific

Hamilton

So-Low

TTP Labtech Ltd

Biolife Solutions

DNA Genotek

Custom Biogenic Systems

LVL Technologies

BioRep

Biobanking Segment by Type

Equipment

Consumable

Biobanking Segment by Application

Virtual Biobanks

Tissue Biobanks

Population Biobanks

Biobanking Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biobanking companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biobanking Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biobanking Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biobanking Market Share by Region (2021-2026) Table 4. Global Biobanking Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biobanking Market Share by Region (2027-2032) Table 6. Global Biobanking Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biobanking Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biobanking Market Size Share by Type (2021-2026) Table 9. Global Biobanking Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biobanking Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biobanking Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biobanking Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biobanking Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biobanking Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biobanking Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biobanking Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biobanking Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biobanking Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biobanking Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biobanking Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biobanking Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biobanking Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biobanking Market Size Share by Application (2021-2026) Table 24. Global Biobanking Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biobanking Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biobanking Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biobanking Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biobanking Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biobanking Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biobanking Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biobanking Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biobanking Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biobanking Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biobanking Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biobanking Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biobanking Industry Trends Table 37. Biobanking Industry Drivers Table 38. Biobanking Industry Opportunities and Challenges Table 39. Biobanking Industry Restraints Table 40. Global Biobanking Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biobanking Revenue Market Share by Company (2021-2026) Table 42. Global Biobanking Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biobanking Key Company Headquarters & Area Served Table 44. Global Biobanking Company, Product Type & Application Table 45. Global Biobanking Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biobanking by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Company Information Table 49. Thermo Fisher Business Overview Table 50. Thermo Fisher Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Biobanking Product Portfolio Table 52. Thermo Fisher Recent Development Table 53. Beckman Coulter Company Information Table 54. Beckman Coulter Business Overview Table 55. Beckman Coulter Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Beckman Coulter Biobanking Product Portfolio Table 57. Beckman Coulter Recent Development Table 58. Panasonic Company Information Table 59. Panasonic Business Overview Table 60. Panasonic Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Panasonic Biobanking Product Portfolio Table 62. Panasonic Recent Development Table 63. SOL Group Company Information Table 64. SOL Group Business Overview Table 65. SOL Group Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. SOL Group Biobanking Product Portfolio Table 67. SOL Group Recent Development Table 68. Promega Company Information Table 69. Promega Business Overview Table 70. Promega Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Promega Biobanking Product Portfolio Table 72. Promega Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck Biobanking Product Portfolio Table 77. Merck Recent Development Table 78. Greiner Bio One Company Information Table 79. Greiner Bio One Business Overview Table 80. Greiner Bio One Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Greiner Bio One Biobanking Product Portfolio Table 82. Greiner Bio One Recent Development Table 83. Chart Industries Company Information Table 84. Chart Industries Business Overview Table 85. Chart Industries Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Chart Industries Biobanking Product Portfolio Table 87. Chart Industries Recent Development Table 88. Brooks Life Science Company Information Table 89. Brooks Life Science Business Overview Table 90. Brooks Life Science Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Brooks Life Science Biobanking Product Portfolio Table 92. Brooks Life Science Recent Development Table 93. Tecan Group Company Information Table 94. Tecan Group Business Overview Table 95. Tecan Group Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Tecan Group Biobanking Product Portfolio Table 97. Tecan Group Recent Development Table 98. QIAGEN Company Information Table 99. QIAGEN Business Overview Table 100. QIAGEN Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. QIAGEN Biobanking Product Portfolio Table 102. QIAGEN Recent Development Table 103. BD Company Information Table 104. BD Business Overview Table 105. BD Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. BD Biobanking Product Portfolio Table 107. BD Recent Development Table 108. Lifeline Scientific Company Information Table 109. Lifeline Scientific Business Overview Table 110. Lifeline Scientific Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Lifeline Scientific Biobanking Product Portfolio Table 112. Lifeline Scientific Recent Development Table 113. Hamilton Company Information Table 114. Hamilton Business Overview Table 115. Hamilton Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Hamilton Biobanking Product Portfolio Table 117. Hamilton Recent Development Table 118. So-Low Company Information Table 119. So-Low Business Overview Table 120. So-Low Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. So-Low Biobanking Product Portfolio Table 122. So-Low Recent Development Table 123. TTP Labtech Ltd Company Information Table 124. TTP Labtech Ltd Business Overview Table 125. TTP Labtech Ltd Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. TTP Labtech Ltd Biobanking Product Portfolio Table 127. TTP Labtech Ltd Recent Development Table 128. Biolife Solutions Company Information Table 129. Biolife Solutions Business Overview Table 130. Biolife Solutions Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Biolife Solutions Biobanking Product Portfolio Table 132. Biolife Solutions Recent Development Table 133. DNA Genotek Company Information Table 134. DNA Genotek Business Overview Table 135. DNA Genotek Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. DNA Genotek Biobanking Product Portfolio Table 137. DNA Genotek Recent Development Table 138. Custom Biogenic Systems Company Information Table 139. Custom Biogenic Systems Business Overview Table 140. Custom Biogenic Systems Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Custom Biogenic Systems Biobanking Product Portfolio Table 142. Custom Biogenic Systems Recent Development Table 143. LVL Technologies Company Information Table 144. LVL Technologies Business Overview Table 145. LVL Technologies Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. LVL Technologies Biobanking Product Portfolio Table 147. LVL Technologies Recent Development Table 148. BioRep Company Information Table 149. BioRep Business Overview Table 150. BioRep Biobanking Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. BioRep Biobanking Product Portfolio Table 152. BioRep Recent Development Table 153. North America Biobanking Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Biobanking Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Biobanking Market Share by Country (2021-2026) Table 156. North America Biobanking Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Biobanking Market Share Forecast by Country (2027-2032) Table 158. Europe Biobanking Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Biobanking Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Biobanking Market Share by Country (2021-2026) Table 161. Europe Biobanking Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Biobanking Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Biobanking Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Biobanking Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Biobanking Market Share by Country (2021-2026) Table 166. Asia-Pacific Biobanking Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Biobanking Market Share Forecast by Country (2027-2032) Table 168. Latin America Biobanking Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Biobanking Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Biobanking Market Share by Country (2021-2026) Table 171. Latin America Biobanking Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Biobanking Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Biobanking Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Biobanking Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Biobanking Market Share by Country (2021-2026) Table 176. Middle East & Africa Biobanking Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Biobanking Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biobanking Product Image Figure 3. Global Biobanking Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biobanking Market Size (2021-2032) & (US$ Million) Figure 5. Global Biobanking Market Share by Region: 2025 VS 2032 Figure 6. Global Biobanking Market Share by Region (2021-2032) Figure 7. North America Biobanking Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biobanking Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biobanking Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biobanking Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biobanking Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Equipment Image Figure 13. Global Equipment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Consumable Image Figure 15. Global Consumable Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Biobanking Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Biobanking Market Share by Type 2025 VS 2032 Figure 18. North America Biobanking Market Size Share by Type (2021-2032) Figure 19. Europe Biobanking Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Biobanking Market Size Share by Type (2021-2032) Figure 21. Latin America Biobanking Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Biobanking Market Size Share by Type (2021-2032) Figure 23. Virtual Biobanks Image Figure 24. Global Virtual Biobanks Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Tissue Biobanks Image Figure 26. Global Tissue Biobanks Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Population Biobanks Image Figure 28. Global Population Biobanks Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Biobanking Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Biobanking Market Share by Application 2025 VS 2032 Figure 31. North America Biobanking Market Size Share by Application (2021-2032) Figure 32. Europe Biobanking Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Biobanking Market Size Share by Application (2021-2032) Figure 34. Latin America Biobanking Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Biobanking Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Biobanking Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Biobanking Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Biobanking Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Biobanking Market Share by Country (2021-2032) Figure 41. Europe Biobanking Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Biobanking Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Biobanking Market Share by Country (2021-2032) Figure 44. Asia-Pacific Biobanking Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Biobanking Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Biobanking Market Share by Country (2021-2032) Figure 47. Latin America Biobanking Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Biobanking Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Biobanking Market Share by Country (2021-2032) Figure 50. Middle East & Africa Biobanking Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Biobanking Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Biobanking Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Consumable
Applications
  • Virtual Biobanks
  • Tissue Biobanks
  • Population Biobanks
Companies covered
  • Thermo Fisher
  • Beckman Coulter
  • Panasonic
  • SOL Group
  • Promega
  • Merck
  • Greiner Bio One
  • Chart Industries
  • Brooks Life Science
  • Tecan Group
  • QIAGEN
  • BD
  • Lifeline Scientific
  • Hamilton
  • So-Low
  • TTP Labtech Ltd
  • Biolife Solutions
  • DNA Genotek
  • Custom Biogenic Systems
  • LVL Technologies
  • BioRep

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biobanking Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biobanking Market Size by Region (2021-2032)
  5. 1.4.1 Global Biobanking Market Size by Region (2021-2026)
  6. 1.4.2 Global Biobanking Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biobanking Market Size (2021-2032)
  8. 1.5.1 North America Biobanking Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biobanking Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biobanking Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biobanking Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biobanking Market Size Growth Rate (2021-2032)
2 Biobanking Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Equipment
  3. 2.1.2 Consumable
  4. 2.2 Global Biobanking Market Size by Type
  5. 2.2.1 Global Biobanking Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Biobanking Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Biobanking Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Biobanking Market Size by Regions
  9. 2.3.1 North America Biobanking Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Biobanking Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Biobanking Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Biobanking Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Biobanking Market Size Breakdown by Type (2021-2026)
3 Biobanking Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Virtual Biobanks
  3. 3.1.2 Tissue Biobanks
  4. 3.1.3 Population Biobanks
  5. 3.2 Global Biobanking Market Size by Application
  6. 3.2.1 Global Biobanking Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Biobanking Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Biobanking Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Biobanking Market Size by Regions
  10. 3.3.1 North America Biobanking Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Biobanking Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Biobanking Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Biobanking Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Biobanking Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biobanking Industry Trends
  2. 4.2 Biobanking Industry Drivers
  3. 4.3 Biobanking Industry Opportunities and Challenges
  4. 4.4 Biobanking Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biobanking Revenue (2021-2026)
  2. 5.2 Global Biobanking Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biobanking Key Company Headquarters & Area Served
  4. 5.4 Global Biobanking Company, Product Type & Application
  5. 5.5 Global Biobanking Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biobanking Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biobanking Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biobanking Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher
  2. 6.1.1 Thermo Fisher Company Information
  3. 6.1.2 Thermo Fisher Business Overview
  4. 6.1.3 Thermo Fisher Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Biobanking Product Portfolio
  6. 6.1.5 Thermo Fisher Recent Developments
  7. 6.2 Beckman Coulter
  8. 6.2.1 Beckman Coulter Company Information
  9. 6.2.2 Beckman Coulter Business Overview
  10. 6.2.3 Beckman Coulter Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Beckman Coulter Biobanking Product Portfolio
  12. 6.2.5 Beckman Coulter Recent Developments
  13. 6.3 Panasonic
  14. 6.3.1 Panasonic Company Information
  15. 6.3.2 Panasonic Business Overview
  16. 6.3.3 Panasonic Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Panasonic Biobanking Product Portfolio
  18. 6.3.5 Panasonic Recent Developments
  19. 6.4 SOL Group
  20. 6.4.1 SOL Group Company Information
  21. 6.4.2 SOL Group Business Overview
  22. 6.4.3 SOL Group Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 SOL Group Biobanking Product Portfolio
  24. 6.4.5 SOL Group Recent Developments
  25. 6.5 Promega
  26. 6.5.1 Promega Company Information
  27. 6.5.2 Promega Business Overview
  28. 6.5.3 Promega Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Promega Biobanking Product Portfolio
  30. 6.5.5 Promega Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck Biobanking Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Greiner Bio One
  38. 6.7.1 Greiner Bio One Company Information
  39. 6.7.2 Greiner Bio One Business Overview
  40. 6.7.3 Greiner Bio One Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Greiner Bio One Biobanking Product Portfolio
  42. 6.7.5 Greiner Bio One Recent Developments
  43. 6.8 Chart Industries
  44. 6.8.1 Chart Industries Company Information
  45. 6.8.2 Chart Industries Business Overview
  46. 6.8.3 Chart Industries Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Chart Industries Biobanking Product Portfolio
  48. 6.8.5 Chart Industries Recent Developments
  49. 6.9 Brooks Life Science
  50. 6.9.1 Brooks Life Science Company Information
  51. 6.9.2 Brooks Life Science Business Overview
  52. 6.9.3 Brooks Life Science Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Brooks Life Science Biobanking Product Portfolio
  54. 6.9.5 Brooks Life Science Recent Developments
  55. 6.10 Tecan Group
  56. 6.10.1 Tecan Group Company Information
  57. 6.10.2 Tecan Group Business Overview
  58. 6.10.3 Tecan Group Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Tecan Group Biobanking Product Portfolio
  60. 6.10.5 Tecan Group Recent Developments
  61. 6.11 QIAGEN
  62. 6.11.1 QIAGEN Company Information
  63. 6.11.2 QIAGEN Business Overview
  64. 6.11.3 QIAGEN Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 QIAGEN Biobanking Product Portfolio
  66. 6.11.5 QIAGEN Recent Developments
  67. 6.12 BD
  68. 6.12.1 BD Company Information
  69. 6.12.2 BD Business Overview
  70. 6.12.3 BD Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 BD Biobanking Product Portfolio
  72. 6.12.5 BD Recent Developments
  73. 6.13 Lifeline Scientific
  74. 6.13.1 Lifeline Scientific Company Information
  75. 6.13.2 Lifeline Scientific Business Overview
  76. 6.13.3 Lifeline Scientific Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Lifeline Scientific Biobanking Product Portfolio
  78. 6.13.5 Lifeline Scientific Recent Developments
  79. 6.14 Hamilton
  80. 6.14.1 Hamilton Company Information
  81. 6.14.2 Hamilton Business Overview
  82. 6.14.3 Hamilton Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Hamilton Biobanking Product Portfolio
  84. 6.14.5 Hamilton Recent Developments
  85. 6.15 So-Low
  86. 6.15.1 So-Low Company Information
  87. 6.15.2 So-Low Business Overview
  88. 6.15.3 So-Low Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 So-Low Biobanking Product Portfolio
  90. 6.15.5 So-Low Recent Developments
  91. 6.16 TTP Labtech Ltd
  92. 6.16.1 TTP Labtech Ltd Company Information
  93. 6.16.2 TTP Labtech Ltd Business Overview
  94. 6.16.3 TTP Labtech Ltd Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 TTP Labtech Ltd Biobanking Product Portfolio
  96. 6.16.5 TTP Labtech Ltd Recent Developments
  97. 6.17 Biolife Solutions
  98. 6.17.1 Biolife Solutions Company Information
  99. 6.17.2 Biolife Solutions Business Overview
  100. 6.17.3 Biolife Solutions Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Biolife Solutions Biobanking Product Portfolio
  102. 6.17.5 Biolife Solutions Recent Developments
  103. 6.18 DNA Genotek
  104. 6.18.1 DNA Genotek Company Information
  105. 6.18.2 DNA Genotek Business Overview
  106. 6.18.3 DNA Genotek Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 DNA Genotek Biobanking Product Portfolio
  108. 6.18.5 DNA Genotek Recent Developments
  109. 6.19 Custom Biogenic Systems
  110. 6.19.1 Custom Biogenic Systems Company Information
  111. 6.19.2 Custom Biogenic Systems Business Overview
  112. 6.19.3 Custom Biogenic Systems Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Custom Biogenic Systems Biobanking Product Portfolio
  114. 6.19.5 Custom Biogenic Systems Recent Developments
  115. 6.20 LVL Technologies
  116. 6.20.1 LVL Technologies Company Information
  117. 6.20.2 LVL Technologies Business Overview
  118. 6.20.3 LVL Technologies Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 LVL Technologies Biobanking Product Portfolio
  120. 6.20.5 LVL Technologies Recent Developments
  121. 6.21 BioRep
  122. 6.21.1 BioRep Company Information
  123. 6.21.2 BioRep Business Overview
  124. 6.21.3 BioRep Biobanking Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 BioRep Biobanking Product Portfolio
  126. 6.21.5 BioRep Recent Developments
7 North America
  1. 7.1 North America Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biobanking Market Size by Country (2021-2026)
  3. 7.3 North America Biobanking Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biobanking Market Size by Country (2021-2026)
  3. 8.3 Europe Biobanking Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biobanking Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biobanking Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biobanking Market Size by Country (2021-2026)
  3. 10.3 South America Biobanking Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biobanking Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biobanking Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research